Kenneth I. Berger
ORCID: 0000-0003-4879-6071Also affiliated with Sanofi (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial”.
Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub +95 more
Gökçen Eraslan, Christian M. Page, Jari Lahti, Marius Lahti-Pulkkinen, Esa Hämäläinen +233 more
Shannon J. Simpson, Kenneth I. Berger, Peter M.A. Calverley, Pedro Lopes de Melo, Ronald J. Dandurand +18 more
Allison Peck, Lindsay N. Alfano, Kenneth I. Berger, M. James, Nupur Ghoshal +50 more
Christopher M. Horvat, Brian C. Stagg, David W. Grainger, Michael J. Lanspa, James F. Orme +65 more
Benjamin G. Wu, Matthew Chung, Bradley Isaacs, Jun-Chieh J. Tsay, Meredith Holub +25 more
Emmanuelle Salort Campana, Shahram Attarian, Jordi Díaz‐Manera, Mazen M. Dimachkie, Magali Periquet +5 more
Kenneth I. Berger, Yian Zhang, Yongzhao Shao, Roberta M. Goldring, Joan Reibman +2 more
Lucy Norcliffe‐Kaufmann, Horacio Kaufmann, Ikoa Jeschke-Lopez, Yu Guo, Judy Zhong +9 more
Brian C. Stagg, Michael J. Lanspa, James F. Orme, Terry P. Clemmer, Lindell K. Weaver +63 more